Literature DB >> 9838960

Seroepidemiologic study of Neospora caninum in dairy herds.

J Paré1, G Fecteau, M Fortin, G Marsolais.   

Abstract

OBJECTIVE: To identify risk factors associated with Neospora caninum infection in dairy herds in Québec and to estimate seroprevalence in case and control herds.
DESIGN: Herd-based case-control and seroprevalence study. ANIMALS: 3,059 cows from 24 case and 22 control dairy herds in Québec. PROCEDURE: Blood samples were obtained from each cow, and sera were tested, using an ELISA, for antibodies to N caninum. Owners of herds answered questionnaires requesting information on demographics and herd management practices. Seroprevalence was compared between case and control herds, using the Mann-Whitney test. Risk factors were compared between case and control herds, using logistic regression.
RESULTS: All case herds and 73% of control herds had at least one seropositive cow. Median seroprevalence was significantly greater among case herds (22.5%) than among control herds (7.5%). Dogs were found most often and in greatest numbers on farms housing case herds compared with control herds during the past 3 years. CLINICAL IMPLICATIONS: Although the exact role that dogs have in transmission of N caninum in dairy herds needs to be elucidated, dogs should have limited access to barns and cattle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9838960

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  15 in total

Review 1.  A review of Neospora caninum in dairy and beef cattle--a Canadian perspective.

Authors:  João Paulo A Haddad; Ian R Dohoo; John A VanLeewen
Journal:  Can Vet J       Date:  2005-03       Impact factor: 1.008

2.  Seroprevalence of infection with Mycobacterium avium subspecies paratuberculosis, bovine leukemia virus, and bovine viral diarrhea virus in maritime Canada dairy cattle.

Authors:  J A VanLeeuwen; G P Keefe; R Tremblay; C Power; J J Wichtel
Journal:  Can Vet J       Date:  2001-03       Impact factor: 1.008

3.  Vertical and horizontal transmission of Neospora caninum in dairy herds in Québec.

Authors:  N Bergeron; G Fecteau; J Paré; R Martineau; A Villeneuve
Journal:  Can Vet J       Date:  2000-06       Impact factor: 1.008

Review 4.  Review of Neospora caninum and neosporosis in animals.

Authors:  J P Dubey; John Dubey
Journal:  Korean J Parasitol       Date:  2003-03       Impact factor: 1.341

5.  Neospora then and now: prevalence of Neospora caninum in Maritime Canada in 1979, 1989, and 1998.

Authors:  G P Keefe; J A VanLeeuwen
Journal:  Can Vet J       Date:  2000-11       Impact factor: 1.008

6.  Seroprevalence of Mycobacterium avium subspecies paratuberculosis, Neospora caninum, Bovine leukemia virus, and Bovine viral diarrhea virus infection among dairy cattle and herds in Alberta and agroecological risk factors associated with seropositivity.

Authors:  H Morgan Scott; Ole Sorensen; John T Y Wu; Eva Y W Chow; Ken Manninen; John A VanLeeuwen
Journal:  Can Vet J       Date:  2006-10       Impact factor: 1.008

7.  Determination and correlation of anti-Neospora caninum antibodies in dogs and cattle from Mexico.

Authors:  G Félix Sánchez; S Elizabeth Morales; M Jóse Martínez; J Francisco Trigo
Journal:  Can J Vet Res       Date:  2003-05       Impact factor: 1.310

8.  Seroprevalence of Neospora caninum infection in dogs from rural and urban environments in Tehran, Iran.

Authors:  H R Haddadzadeh; A Sadrebazzaz; A Malmasi; H Talei Ardakani; P Khazraii Nia; N Sadreshirazi
Journal:  Parasitol Res       Date:  2007-08-09       Impact factor: 2.289

Review 9.  Epidemiology and control of neosporosis and Neospora caninum.

Authors:  J P Dubey; G Schares; L M Ortega-Mora
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

10.  Diagnostic accuracy of enzyme-linked immunosorbent assay (ELISA) and immunoblot (IB) for the detection of antibodies against Neospora caninum in milk from dairy cows.

Authors:  I P Chatziprodromidou; T Apostolou
Journal:  Epidemiol Infect       Date:  2017-12-22       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.